Back
Vertex Pharmaceuticals Vs. Kinsale Capital Group Industry Stock Comparison
Buy
71
VRTX
Vertex Pharmaceuticals
Last Price:
445.72
Seasonality Move:
7.52%
Buy
53
KNSL
Kinsale Capital Group
Last Price:
385.84
Seasonality Move:
21.78%
Buy
71
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $445.21. The Score for VRTX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Kinsale Capital Group (KNSL)
is a Buy
Is Kinsale Capital Group a Buy, Sell or Hold?
- The current Kinsale Capital Group [KNSL] share price is $390.92. The Score for KNSL is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- KNSL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $445.21
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
KNSL Stock Price Chart
What is Kinsale Capital Group's stock price today?
-
The Kinsale Capital Group share price today is $390.92
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KNSL is experiencing buying pressure, which is a positive indicator for future bullish movement.
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.17 | Buy |
| Relative Strength Index (14 RSI): | 79.02 | Buy |
| Chaikin Money Flow: | 929485 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (392.72 - 424.92) | Buy |
| Bollinger Bands (100): | (403.76 - 430.1) | Buy |
KNSL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -18.64 | Sell |
| Relative Strength Index (14 RSI): | 41.46 | Sell |
| Chaikin Money Flow: | 123643 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (369.98 - 443.88) | Sell |
| Bollinger Bands (100): | (375.22 - 497.86) | Sell |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 430.31 | Buy |
| 20-day SMA: | 412.4 | Buy |
| 50-day SMA: | 409.66 | Buy |
| 200-day SMA: | 388.13 | Buy |
| 8-day EMA: | 430.92 | Buy |
| 20-day EMA: | 418.59 | Buy |
| 50-day EMA: | 412.7 | Buy |
| 200-day EMA: | 390.21 | Buy |
KNSL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 382.37 | Buy |
| 20-day SMA: | 395.92 | Sell |
| 50-day SMA: | 450.87 | Sell |
| 200-day SMA: | 409.51 | Sell |
| 8-day EMA: | 385.02 | Buy |
| 20-day EMA: | 398.6 | Sell |
| 50-day EMA: | 425.85 | Sell |
| 200-day EMA: | 407.71 | Sell |
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.78 per share, an increase this year of $2.05 per share, and an increase next year of $1.12 per share.
Kinsale Capital Group Earnings Growth & KNSL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.78 per share, an increase next quarter of $0.67 per share, an increase this year of $2.79 per share, and an increase next year of $2.61 per share.
Vertex Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kinsale Capital Group Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||